In a transplantable model of B16 melanoma cells the presence of microglia (CD11b+F4/80+CD45low) infiltration into intracranial B16 melanoma tumors increased following combined PD-1/CTLA-4 blockade and the increase in microglia correlated with intracranial therapeutic efficacy. This evidence concerns the gene ITGAM and melanoma.